muse

(redirected from alprostadil)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.
Related to alprostadil: papaverine

muse

a goddess that inspires a creative artist, esp a poet

Muse

(language)
OR-parallel logic programming.

MUSE

(1) (MultiUser Simulation Environment, MultiUser Shared Environment) See MUD.

(2) (MUltiple Sub-Nyquist sampling Encoding) The compression system used in Japan's first HD TV system. See Hi-Vision.

(3) A computer developed at the University of Manchester in the late 1950s. See BABY.
References in periodicals archive ?
Alprostadil relaxes muscles in erectile tissue of the penis, allowing blood to flow in.
Men who can't tolerate any PDE-5 inhibitor or who are among the 20%-30% who don't respond can try Alprostadil in injection or pellet form.
A system for inserting a pellet of alprostadil into the urethra is marketed as Muse.
Even more encouraging, especially for men who cannot stand the thought of using a needle, is the recent availability of alprostadil in the form of a tiny "seed" one places in the urethral opening at the tip of the penis, where it is quickly absorbed.
Apricus Bio incorporated alprostadil with its NexACT delivery technology, resulting in a rapid and efficient topical delivery of the drug into the penis.
In a double-blind, placebo-controlled study patients were randomized to either placebo or topical alprostadil in 100- or 400-[micro]g doses.
With both issued and pending patents, the company believes it has the dominant patent position for the local delivery of prostaglandins, such as alprostadil, in the treatment of women with FSD.
However, it may become possible one day to administer the prostaglandin through a noninjectable means called transurethral alprostadil, which works by delivering alprostadil through the urethra in a small single-dose plastic applicator.
Food & Drug Administration (FDA) has granted the Company an Investigational New Drug application number for its NexACT-based alprostadil treatment for Raynaud's syndrome, ahead of a pre-IND meeting in mid-July 2010 to discuss its proposed Phase 2/3 protocol.
Presentation Title: A randomized, placebo-controlled, double-blind, parallel design study of the efficacy and safety of specially formulated alprostadil topical cream in patients with female sexual arousal disorder.
ALIBRA, a local therapy, consists of two drugs, alprostadil and prazosin HCl, formulated into a microsuppository and delivered to the urethra (urine tube) via a single-use plastic applicator.